Clinica Baviera (ES:CBAV) has released an update.
Clinica Baviera has executed a share repurchase program between July 8 and July 12, 2024, as part of a scheme approved by the board and authorized by the general shareholders’ meeting in 2020. The transactions involved buying back shares on multiple dates at various average prices, continuing the company’s strategic efforts to manage its capital.
For further insights into ES:CBAV stock, check out TipRanks’ Stock Analysis page.
